TD-1792

· Theravance Biopharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TD-1792, covering 2021-01-20 to 2021-01-20. Get the full timeline:

Most recent: Clinical Trial Update: TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection [Phase 2]